PEGS Boston Summit 2026

On May 11–15, 2026, meet us at the 22^nd Annual PEGS Boston Summit —  the premier event shaping the future of biologics. Explore innovations in protein and antibody engineering, drug development, immunotherapy, radiotherapy, and AI/ML-driven biologics research.

Discover how Genedata solutions digitalize and automate R&D workflows for biotherapeutics and vaccines — covering screening, engineering, expression, purification, analysis, cell line development, bioprocess optimization, MS- and NGS-based quality control, and clinical trial design.

Join the talks below to learn how customers benefit from our solution:

Challenges in Digital Representation and Bioanalytical Characterization of Antibody-Drug Conjugates
Joel Bard, PhD, Research Fellow, Bioinformatics, BioMedicine Design, Pfizer
ML and Digital Integration in Biotherapeutic Analytics
Monday, May 11 |  8:30 AM

KEYNOTE PRESENTATION: From Targets to Biologics: AI Powering the Next Leap in Discovery at Takeda
Yves Fomekong Nanfack, PhD, Head of AI/ML Research, Takeda  
ML and Digital Integration in Biotherapeutic Analytics
Monday, May 11 | 9:30 AM

Integrating Machine Learning and In-Silico Property Prediction into a Computational Workflow to Support CMC Development
Colin Stackhouse, Senior Scientist, Biologics Analytical Development, Johnson & Johnson Innovative Medicine
ML and Digital Integration in Biotherapeutic Analytics
Monday, May 11 | 1:50 PM

Automating MS Analytical Workflows for Novel Biologics
David Bush, PhD, Principal Scientist, Novartis Institutes for BioMedical Research
Biophysical Methods
Wednesday, May 13 | 1:40 PM